البحث | Friends - Best Social Network - החברים

Devidi Jahnavi أضاف وظيفة جديدة Health
2025-06-18 05:08:46

Emerging Biomarkers in Idiopathic Pulmonary Fibrosis Management
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive interstitial lung disease defined by irreversible scarring of lung tissue. While it has long presented challenges due to late diagnosis and limited treatment options, recent clinical advances and heightened awareness are shifting the treatment paradigm. As novel antifibrotic therapies evolve and precision approaches become integrated...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Aarya Jain أضاف وظيفة جديدة Networking
2025-07-08 08:42:43

Neurological Biomarkers Market on Track to Redefine Global Standards by 2032
Market Overview The global neurological biomarkers market was valued at USD 8.29 billion in 2023 and is expected to grow at a CAGR of 13.00% during the forecast period. The neurological biomarkers market encompasses biomolecules, imaging markers, electrophysiological indicators, and genetic signatures that can help detect and monitor brain-related conditions. These biomarkers are...

0 التعليقات 0 المشاركات 1كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Ashish Jagtap أضاف وظيفة جديدة Health
2025-08-01 12:07:06

Neurological Biomarkers Market Outlook 2025–2033: Size, Trends, Growth Drivers & Regional Breakdown
Neurological Biomarkers Market Size According to Straits Research, The global Neurological Biomarkers Market size was valued at USD 9973.78 million in 2024. It is projected to reach USD 29747.57 million by 2033, growing at a CAGR of 12.91% during the forecast period (2025-2033). The global market represents a dynamic convergence of information technology and the...

0 التعليقات 0 المشاركات 641 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Uttej Netha أضاف وظيفة جديدة Health
2025-06-24 07:36:13

AI and Genomics Revolutionize Liquid Biopsy Technologies
The global Liquid Biopsy Market is projected to expand from USD 3.8 billion in 2023 to USD 9.4 billion by 2032, growing at a robust CAGR of 10.7% during the forecast period (2024–2032). This rapid growth is fueled by increasing demand for non-invasive diagnostic methods, rising cancer incidence globally, and expanding applications of precision oncology. Liquid biopsy is transforming...

0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!